Showing results (211-220 of 445) with videos related to

Sort By:
Pageof 45
Clinical Endocrinology|December 1, 1995
Prevalence of Helicobacter pylori in acromegalic patients during treatment with octreotideS L Jones, S Patchett, J V Anderson, et al.
British Medical Journal|July 23, 1977
Metyrapone in long-term management of Cushing's diseaseW J Jeffcoate, L H Rees, S Tomlin, et al.
Clinical Endocrinology|September 1, 1992
Prevalence of gastritis in patients with acromegaly: untreated and during treatment with octreotideJ V Anderson, S Catnach, D G Lowe, et al.
Clinical Endocrinology|April 18, 2003
The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarismA M Isidori, G A Kaltsas, L Perry, et al.
European Journal of Endocrinology|October 3, 2001
Successful treatment of resistant acromegaly with a growth hormone receptor antagonistW M Drake, C Parkinson, S A Akker, et al.
Clinical Endocrinology|October 1, 1994
Treatment with GHRH(1-29)NH2 in children with idiopathic short stature induces a sustained increase in growth velocityJ M Kirk, P J Trainer, W H Majrowski, et al.
Clinical Science (London, England : 1979)|June 1, 1989
Differential effect of high-dose naloxone on the plasma adrenaline response to the cold-pressor testP M Bouloux, E Newbould, R Causon, et al.
Clinical Endocrinology|January 13, 2001
Optimal dosage interval for depot somatostatin analogue therapy in acromegaly requires individual titrationP J Jenkins, S Akker, S L Chew, et al.
European Journal of Endocrinology|March 15, 2005
Disease activity in acromegaly may be assessed 6 weeks after discontinuation of pegvisomantW M Drake, R A Loureiro, C Parkinson, et al.
Clinical Endocrinology|July 1, 1991
The use of venous catheterization in the diagnosis and localization of bilateral phaeochromocytomasE C Newbould, G A Ross, J E Dacie, et al.
Pageof 45